Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development

被引:0
|
作者
Yanying Huo
Pier Selenica
Amar H. Mahdi
Fresia Pareja
Kelly Kyker-Snowman
Ying Chen
Rahul Kumar
Arnaud Da Cruz Paula
Thais Basili
David N. Brown
Xin Pei
Nadeem Riaz
Yongmei Tan
Yu-Xiu Huang
Tao Li
Nicola J. Barnard
Jorge S. Reis-Filho
Britta Weigelt
Bing Xia
机构
[1] Rutgers Cancer Institute of New Jersey,Department of Radiation Oncology
[2] Rutgers Robert Wood Johnson Medical School,Department of Pathology
[3] Memorial Sloan Kettering Cancer Center,Department of Radiation Oncology
[4] Memorial Sloan Kettering Cancer Center,Department of Pathology and Laboratory Medicine
[5] Stomatological Hospital of Guangzhou Medical University,Department of Physiology, College of Medicine
[6] The First Affiliated Hospital of Fujian Medical University,Centre for Brain Research
[7] Rutgers Robert Wood Johnson Medical School,undefined
[8] Al-Mustansiriyah University,undefined
[9] Indian Institute of Science (IISc),undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Inherited mutations in BRCA1, BRCA2, and PALB2 cause a high risk of breast cancer. Here, we conducted parallel conditional knockout (CKO) of Brca1, Palb2, and Brca2, individually and in combination, along with one copy of Trp53, in the mammary gland of nulliparous female mice. We observed a functional equivalence of the three genes in their basic tumor-suppressive activity, a linear epistasis of Palb2 and Brca2, but complementary roles of Brca1 and Palb2 in mammary tumor suppression, as combined ablation of either Palb2 or Brca2 with Brca1 led to delayed tumor formation. Whole-exome sequencing (WES) revealed both similarities and differences between Brca1 and Palb2 or Brca2 null tumors. Analyses of mouse mammary glands and cultured human cells showed that combined loss of BRCA1 and PALB2 led to high levels of reactive oxygen species (ROS) and increased apoptosis, implicating oxidative stress in the delayed tumor development in Brca1;Palb2 double CKO mice. The functional complementarity between BRCA1 and PALB2/BRCA2 and the role of ROS in tumorigenesis require further investigation.
引用
收藏
相关论文
共 50 条
  • [1] Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development
    Huo, Yanying
    Selenica, Pier
    Mahdi, Amar H.
    Pareja, Fresia
    Kyker-Snowman, Kelly
    Chen, Ying
    Kumar, Rahul
    Da Cruz Paula, Arnaud
    Basili, Thais
    Brown, David N.
    Pei, Xin
    Riaz, Nadeem
    Tan, Yongmei
    Huang, Yu-Xiu
    Li, Tao
    Barnard, Nicola J.
    Reis-Filho, Jorge S.
    Weigelt, Britta
    Xia, Bing
    NPJ BREAST CANCER, 2021, 7 (01)
  • [2] PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
    Zhang, Feng
    Ma, Jianglin
    Wu, Jiaxue
    Ye, Lin
    Cai, Hong
    Xia, Bing
    Yu, Xiaochun
    CURRENT BIOLOGY, 2009, 19 (06) : 524 - 529
  • [3] Mammary Tumor Development in Dogs Is Associated with BRCA1 and BRCA2
    Rivera, Patricio
    Melin, Malin
    Biagi, Tara
    Fall, Tove
    Haggstrom, Jens
    Lindblad-Toh, Kerstin
    von Euler, Henrik
    CANCER RESEARCH, 2009, 69 (22) : 8770 - 8774
  • [4] PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2
    Zhang, Fan
    Fan, Qiang
    Ren, Keqin
    Andreassen, Paul R.
    MOLECULAR CANCER RESEARCH, 2009, 7 (07) : 1110 - 1118
  • [5] Clinicopathological significance of mutations in BRCA1, BRCA2, and PALB2 in pancreatic ductal adenocarcinoma
    Takeuchi, Shoko
    Doi, Manami
    Ikari, Naoki
    Yamamoto, Masakazu
    Furukawa, Toru
    CANCER SCIENCE, 2018, 109 : 755 - 755
  • [6] PALB2 Physically and Functionally Connects BRCA1 and BRCA2 into a Pathway of Homologous Recombination
    Zhang, F.
    Fan, Q.
    Ren, K.
    Andreassen, P. R.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2009, 50 (07) : 554 - 554
  • [7] PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response
    Srilatha Simhadri
    Gabriele Vincelli
    Yanying Huo
    Sarah Misenko
    Tzeh Keong Foo
    Johanna Ahlskog
    Claus S. Sørensen
    Gregory G. Oakley
    Shridar Ganesan
    Samuel F. Bunting
    Bing Xia
    Oncogene, 2019, 38 : 1585 - 1596
  • [8] PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response
    Simhadri, Srilatha
    Vincelli, Gabriele
    Huo, Yanying
    Misenko, Sarah
    Foo, Tzeh Keong
    Ahlskog, Johanna
    Sorensen, Claus S.
    Oakley, Gregory G.
    Ganesan, Shridar
    Bunting, Samuel F.
    Xia, Bing
    ONCOGENE, 2019, 38 (10) : 1585 - 1596
  • [9] Validation of a next generation sequencing assay for BRCA1, BRCA2, CHEK2 and PALB2 genetic testing
    Sim, Wey Cheng
    Lee, Chee Yang
    Richards, Rebecca
    Bettens, Karolien
    Mottier, Violaine
    Goh, Liuh Ling
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2020, 116
  • [10] The frequency of HER2-low breast cancer among BRCA1, BRCA2, and PALB2 mutation carriers
    Goldblatt, Lindsay
    Coutifaris, Paulina
    Shah, Payal Deepak
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)